Monday, 27 June, 2022
HomeHealthDrug authority clears Covaxin, Corbevax for children aged 5 to 12

Drug authority clears Covaxin, Corbevax for children aged 5 to 12

DGCI also allowed emergency use of Zycov-D (Zydus Cadila vaccine) for children above 12 years.

Text Size:

New Delhi: The Drugs Controller General of India (DGCI) on Tuesday gave restricted use to Bharat Biotech’s Covaxin for children between six and 12 years of age.

The company has been asked to submit regular data for the next five months on any adverse effects the vaccine may have. Covaxin is already being given to children above 12 years of age.

The drug authority also granted emergency use of the Corbevax vaccine for children between 5 and 12 years.

Corbevax, manufactured by the Hyderabad-based Biological-E, is India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine.

Further on Tuesday, the drug controller allowed the emergency use of Zycov-D (Zydus Cadila vaccine) for children above 12 years of age.

ZyCoV-D is India’s second indigenously developed coronavirus vaccine after Hyderabad-based Bharat Biotech’s Covaxin.


Also read: The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Most Popular

×